<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0376441</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6691</journal-id>
<journal-id journal-id-type="nlm-ta">Prog Brain Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Prog. Brain Res.</journal-id>
<journal-title-group>
<journal-title>Progress in brain research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0079-6123</issn>
<issn pub-type="epub">1875-7855</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28554401</article-id>
<article-id pub-id-type="pmc">6263167</article-id>
<article-id pub-id-type="doi">10.1016/bs.pbr.2016.11.005</article-id>
<article-id pub-id-type="manuscript">NIHMS996052</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transplantation of GABAergic interneurons for cell-based therapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Spatazza</surname>
<given-names>J.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mancia Leon</surname>
<given-names>W.R.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alvarez-Buylla</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="corresp" rid="CR1">1</xref>
</contrib>
<aff id="A1">The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, United States</aff>
</contrib-group>
<author-notes>
<corresp id="CR1"><label>1</label>Corresponding author: Tel.: 415-514-2348; Fax: 415-514-2346, <email>abuylla@stemcell.ucsf.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>231</volume>
<fpage>57</fpage>
<lpage>85</lpage>
<!--elocation-id from pubmed: 10.1016/bs.pbr.2016.11.005-->
<abstract id="ABS1">
<p id="P1">Many neurological disorders stem from defects in or the loss of specific neurons. Neuron transplantation has tremendous clinical potential for central nervous system therapy as it may allow for the targeted replacement of those cells that are lost in diseases. Normally, most neurons are added during restricted periods of embryonic and fetal development. The permissive milieu of the developing brain promotes neuronal migration, neuronal differentiation, and synaptogenesis. Once this active period of neurogenesis ends, the chemical and physical environment of the brain changes dramatically. The brain parenchyma becomes highly packed with neuronal and glial processes, extracellular matrix, myelin, and synapses. The migration of grafted cells to allow them to home into target regions and become functionally integrated is a key challenge to neuronal transplantation. Interestingly, transplanted young telencephalic inhibitory interneurons are able to migrate, differentiate, and integrate widely throughout the postnatal brain. These grafted interneurons can also functionally modify local circuit activity. These features have facilitated the use of interneuron transplantation to study fundamental neurodevelopmental processes including cell migration, cell specification, and programmed neuronal cell death. Additionally, these cells provide a unique opportunity to develop interneuron-based strategies for the treatment of diseases linked to interneuron dysfunction and neurological disorders associated to circuit hyperexcitability.</p>
</abstract>
<kwd-group>
<kwd>Interneuron</kwd>
<kwd>Ganglionic eminence</kwd>
<kwd>Transplantation</kwd>
<kwd>Plasticity</kwd>
<kwd>Epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>